Abstract
A previous study indicated a causal link between certain miRNAs induced by obesity and the development of hepatic insulin resistance and type 2 diabetes. Here we provide accompanying data collected using Affymetrix GeneChip miRNAs microarrays to identify the changes in miRNAs expression in the liver of mice fed a high fat diet (HFD). Differentially expressed microRNA analyses in the liver of the HFD-fed mice revealed a range of upregulated (>1.5-fold) or downregulated (<0.5-fold) miRNAs. Among those upregulated miRNAs, in silico target analysis, such as TargetScan, PicTar, and miRWalk, identified miRNAs with the putative binding sites on the 3’UTRs of INSR and/or IRS-1. Interpretation of the data and further extensive insights into the implication of miRNAs, particularly miR-15b, in hepatic insulin resistance can be found in "Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes." (W.M. Yang, H.J. Jeong, S.W. Park, W. Lee, 2015)[1].
Keywords: MicroRNAs, High fat diet, Saturated fatty acids, Obesity, Liver, Mice
Specifications Table
Subject area | Biology, Biochemistry |
---|---|
More specific subject area | Obesity, Metabolism, MicroRNA |
Type of data | Tables and Excel files |
How data was acquired | Affymetrix GeneChip microarray analyses of miRNAs |
Data format | Analyzed |
Experimental factors | Diet-induced obesity, RNA Isolation, Affymetrix Genechip miRNA microarray, In silico analysis of miRNAs |
Experimental features | Differentially expressed miRNAs of the liver of mice fed with either a NFD or a HFD were analyzed using Affymetrix GeneChip miRNA microarray. |
Data source location | Dongguk University School of Medicine, Gyeongju 780-714, Korea |
Data accessibility | The data are available with this article |
Value of the data
-
•
The data can allow a prediction of the biological significance of miRNAs associated with the pathogenesis of obesity, insulin resistance and type 2 diabetes.
-
•
The data can be compared with miRNA analysis from other cell or tissue types with obesity.
-
•
Differentially expressed miRNAs in this dataset could be applied to further study the changes in the cellular phenotype by high fat diet-induced obesity and metabolic diseases.
-
•
The results support a previous study [1] and the use of transcriptomic technologies in non-model organisms.
1. Data
Diets rich in saturated fatty acids (SFA) can exacerbate obesity [2] and increase the risk of insulin resistance. This condition is characterized by an inadequate response of the insulin-sensitive tissues to insulin, leading to type 2 diabetes and metabolic syndrome [3]. Obesity modulates aberrantly the expression of certain miRNAs targeting the mRNAs of the insulin signaling molecules, and participates actively in the pathogenesis of insulin resistance [4], [5]. A previous study reported that a high fat diet (HFD) induces miR-15b in the liver of mice, which suppresses the expression of hepatic INSR, but not IRS-1, by targeting INSR 3’UTR directly [1]. Therefore, certain types of miRNA induced by obesity can be linked causally to the development of hepatic insulin resistance, which may in turn lead to type 2 diabetes. This study provides accompanying data collected using Affymetrix GeneChip microarrays to identify the changes in miRNA expression in the liver of mice fed with a HFD for 14 weeks. Differentially expressed miRNA analyses in the liver of HFD-fed mice showed that a range of miRNAs were upregulated more than 1.5-fold (Supplement File. 1) or downregulated less than 0.5-fold (Supplement File. 2). Among those differentially expressed miRNAs, the upregulated miRNAs may be involved in the reduction of INSR and IRS-1 levels observed in the liver of HFD-fed mice. Therefore, this study next examined whether the 3’UTRs of INSR and IRS-1 possess direct binding sites for the upregulated miRNAs. In silico target analysis using TargetScan, PicTar, and miRWalk showed that a range of certain miRNAs have putative binding sites for the 3’UTRs of INSR (Table 1) and/or IRS-1 (Table 2). An interpretation of the data and further extensive insights into the implication of miRNAs, particularly miR-15b, in hepatic insulin resistance can be found elsewhere [1].
Table 1.
miRNAs | Fold change | Accession | Sequence |
---|---|---|---|
miR-15b-5p | 1.62 | MIMAT0000124 | UAGCAGCACAUCAUGGUUUACA |
miR-28a-5p | 1.58 | MIMAT0000653 | AAGGAGCUCACAGUCUAUUGAG |
miR-28a-3p | 1.86 | MIMAT0004661 | CACUAGAUUGUGAGCUGCUGGA |
miR-132-3p | 2.15 | MIMAT0000144 | UAACAGUCUACAGCCAUGGUCG |
miR-140-3p | 1.73 | MIMAT0000152 | UACCACAGGGUAGAACCACGG |
miR-149-5p | 16.27 | MIMAT0000159 | UCUGGCUCCGUGUCUUCACUCCC |
miR-151-3p | 1.93 | MIMAT0000161 | CUAGACUGAGGCUCCUUGAGG |
miR-181a-5p | 2.21 | MIMAT0000210 | AACAUUCAACGCUGUCGGUGAGU |
miR-183-5p | 1.51 | MIMAT0000212 | UAUGGCACUGGUAGAAUUCACU |
miR-193a-5p | 1.77 | MIMAT0004544 | UGGGUCUUUGCGGGCAAGAUGA |
miR-212-3p | 3.23 | MIMAT0000659 | UAACAGUCUCCAGUCACGGCCA |
miR-292b-5p | 2.83 | MIMAT0029864 | ACUCAAAACCUGGCGGCACUUUU |
miR-296-3p | 1.78 | MIMAT0004576 | GAGGGUUGGGUGGAGGCUCUCC |
miR-322-5p | 1.64 | MIMAT0000548 | CAGCAGCAAUUCAUGUUUUGGA |
miR-326-3p | 2.04 | MIMAT0000559 | CCUCUGGGCCCUUCCUCCAGU |
miR-330-3p | 2.35 | MIMAT0000569 | GCAAAGCACAGGGCCUGCAGAGA |
miR-330-5p | 1.62 | MIMAT0004642 | UCUCUGGGCCUGUGUCUUAGGC |
miR-342-3p | 1.50 | MIMAT0000590 | UCUCACACAGAAAUCGCACCCGU |
miR-375-3p | 1.51 | MIMAT0000739 | UUUGUUCGUUCGGCUCGCGUGA |
miR-376c-3p | 1.86 | MIMAT0003183 | AACAUAGAGGAAAUUUCACGU |
miR-378a-3p | 1.54 | MIMAT0003151 | ACUGGACUUGGAGUCAGAAGG |
miR-383-5p | 1.66 | MIMAT0000748 | AGAUCAGAAGGUGACUGUGGCU |
miR-410-3p | 1.51 | MIMAT0001091 | AAUAUAACACAGAUGGCCUGU |
miR-421-3p | 1.57 | MIMAT0004869 | AUCAACAGACAUUAAUUGGGCGC |
miR-455-3p | 2.71 | MIMAT0003742 | GCAGUCCACGGGCAUAUACAC |
miR-455-5p | 1.53 | MIMAT0003485 | UAUGUGCCUUUGGACUACAUCG |
miR-532-3p | 3.81 | MIMAT0004781 | CCUCCCACACCCAAGGCUUGCA |
miR-532-5p | 1.62 | MIMAT0002889 | CAUGCCUUGAGUGUAGGACCGU |
miR-1224-5p | 3.40 | MIMAT0005460 | GUGAGGACUGGGGAGGUGGAG |
Table 2.
miRNAs | Fold change | Accession | Sequence |
---|---|---|---|
miR-15b-5p | 1.62 | MIMAT0000124 | UAGCAGCACAUCAUGGUUUACA |
miR-28a-3p | 1.86 | MIMAT0004661 | CACUAGAUUGUGAGCUGCUGGA |
miR-92b-3p | 2.81 | MIMAT0004899 | UAUUGCACUCGUCCCGGCCUCC |
miR-125a-5p | 2.15 | MIMAT0000135 | UCCCUGAGACCCUUUAACCUGUGA |
miR-149-5p | 16.27 | MIMAT0000159 | UCUGGCUCCGUGUCUUCACUCCC |
miR-151-5p | 1.66 | MIMAT0004536 | UCGAGGAGCUCACAGUCUAGU |
miR-155-5p | 1.76 | MIMAT0000165 | UUAAUGCUAAUUGUGAUAGGGGU |
miR-181a-5p | 2.21 | MIMAT0000210 | AACAUUCAACGCUGUCGGUGAGU |
miR-181b-5p | 2.96 | MIMAT0000673 | AACAUUCAUUGCUGUCGGUGGGU |
miR-181d-5p | 1.52 | MIMAT0004324 | AACAUUCAUUGUUGUCGGUGGGU |
miR-183-5p | 1.51 | MIMAT0000212 | UAUGGCACUGGUAGAAUUCACU |
miR-200c-3p | 1.51 | MIMAT0000657 | UAAUACUGCCGGGUAAUGAUGGA |
miR-296-3p | 1.78 | MIMAT0004576 | GAGGGUUGGGUGGAGGCUCUCC |
miR-322-5p | 1.64 | MIMAT0000548 | CAGCAGCAAUUCAUGUUUUGGA |
miR-325-3p | 1.55 | MIMAT0004640 | UUUAUUGAGCACCUCCUAUCAA |
miR-328-3p | 2.20 | MIMAT0000565 | CUGGCCCUCUCUGCCCUUCCGU |
miR-330-3p | 2.35 | MIMAT0000569 | GCAAAGCACAGGGCCUGCAGAGA |
miR-339-5p | 2.13 | MIMAT0000584 | UCCCUGUCCUCCAGGAGCUCACG |
miR-340-5p | 1.54 | MIMAT0004651 | UUAUAAAGCAAUGAGACUGAUU |
miR-342-3p | 1.50 | MIMAT0000590 | UCUCACACAGAAAUCGCACCCGU |
miR-370-3p | 1.51 | MIMAT0001095 | GCCUGCUGGGGUGGAACCUGGU |
miR-375-3p | 1.51 | MIMAT0000739 | UUUGUUCGUUCGGCUCGCGUGA |
miR-376c-3p | 1.86 | MIMAT0003183 | AACAUAGAGGAAAUUUCACGU |
miR-383-5p | 1.66 | MIMAT0000748 | AGAUCAGAAGGUGACUGUGGCU |
miR-410-3p | 1.51 | MIMAT0001091 | AAUAUAACACAGAUGGCCUGU |
miR-421-3p | 1.57 | MIMAT0004869 | AUCAACAGACAUUAAUUGGGCGC |
miR-423-3p | 1.86 | MIMAT0003454 | AGCUCGGUCUGAGGCCCCUCAGU |
miR-455-3p | 2.71 | MIMAT0003742 | GCAGUCCACGGGCAUAUACAC |
miR-455-5p | 1.53 | MIMAT0003485 | UAUGUGCCUUUGGACUACAUCG |
miR-466c-5p | 2.09 | MIMAT0004877 | UGAUGUGUGUGUGCAUGUACAUAU |
miR-466i-5p | 1.78 | MIMAT0017325 | UGUGUGUGUGUGUGUGUGUG |
miR-466m-5p | 1.78 | MIMAT0014882 | UGUGUGCAUGUGCAUGUGUGUAU |
miR-500-3p | 2.29 | MIMAT0003507 | AAUGCACCUGGGCAAGGGUUCA |
miR-501-3p | 1.73 | MIMAT0003509 | AAUGCACCCGGGCAAGGAUUUG |
miR-532-5p | 1.62 | MIMAT0002889 | CAUGCCUUGAGUGUAGGACCGU |
miR-669a-5p | 2.31 | MIMAT0003477 | AGUUGUGUGUGCAUGUUCAUGUCU |
miR-669f-5p | 1.87 | MIMAT0017327 | AGUUGUGUGUGCAUGUGCAUGUGU |
miR-669k-5p | 1.85 | MIMAT0017323 | UGUGCAUGUGUGUAUAGUUGUGUGC |
miR-669l-5p | 1.87 | MIMAT0009418 | AGUUGUGUGUGCAUGUAUAUGU |
miR-669m-5p | 1.78 | MIMAT0017346 | UGUGUGCAUGUGCAUGUGUGUAU |
miR-669p-5p | 2.31 | MIMAT0014889 | AGUUGUGUGUGCAUGUUCAUGUCU |
miR-1197-3p | 1.51 | MIMAT0005858 | UAGGACACAUGGUCUACUUCU |
miR-3102-5p | 1.79 | MIMAT0014933 | GUGAGUGGCCAGGGUGGGGCUG |
miR-3102-5p.2-5p | 1.88 | MIMAT0014934 | GGUGGUGCAGGCAGGAGAGCC |
miR-3473a | 1.77 | MIMAT0015645 | UGGAGAGAUGGCUCAGCA |
miR-3473b | 1.71 | MIMAT0020367 | GGGCUGGAGAGAUGGCUCAG |
miR-3473d | 2.35 | MIMAT0020632 | CCACUGAGCCACUUUCCAGCCCUU |
2. Experimental design, materials and methods
2.1. Animals and high fat diet (HFD)-induced obesity
All The Animal Use and Care Committee at Dongguk University approved all experimental procedures involving mice. The C57BL/6N male mice were purchased from OrientBio (Seongnam, Gyeonggi, Korea). They were maintained in a temperature (20–22 °C) and humidity (55±10%) controlled facility with a 12:12 h light–dark cycle and given access to food and water ad libitum. At 6 weeks of age, the mice were fed either a normal fat diet (NFD, 12.4% calories from fat; Purina, Wilkes-Barre, PA, USA) or a HFD (60% calories from fat; Dyets Inc., Bethlehem, PA, USA) for 14 weeks. During the experimental period, the body weights of the mice were recorded weekly. At the end of the experiment, mice were fasted for 12 h and sacrificed by a cervical dislocation. The liver was removed rapidly, washed with cold PBS, and subjected to RNA extraction.
2.2. RNA extraction and quality check
The total RNA from the liver of mice was extracted using a miRNeasy Mini Kit (Qiagen) according to the manufacturer׳s instructions. The purity and integrity of the RNA extracted were assessed using a ND-1000 Spectrophotometer (NanoDrop) and Agilent 2100 Bioanalyzer (Agilent Technologies). Equal amounts of RNA from five mice were combined and used for the microarray.
2.3. miRNA arrays analysis
The total RNA from the liver of the mice described above was prepared and subjected to the Affymetrix Genechip miRNA 4.0 array (Affymetrix) process according to the Affymetrix technical instructions. Briefly, 600ng of RNA was labeled with a FlashTag™ Biotin RNA Labeling Kit (Genisphere, Hatfield, PA, USA). The labeled RNA was quantified, fractionated, and hybridized to the miRNA microarray provided by the manufacture. The labeled RNA was heated to 99 °C for 5 min and incubated to 45 °C for 5 min. RNA-array hybridization was conducted with agitation at 60 rpm for 16 h at 48 °C on an Affymetrix® 450 Fluidics Station. The chips were stained using a Genechip Fluidics Station 450 (Affymetrix), and scanned with an Affymetrix GCS 3000 scanner (Affymetrix). All signals were normalized using the quantile method after a log2 transformation to make them comparable across the microarrays.
2.4. Data extraction and in silico analysis
Differentially expressed miRNAs were analyzed automatically using Affymetrix® GeneChip™ Command Console software according to the Affymetrix data extraction protocol and identified by calculating the fold change of either a NFD-fed mice versus a HFD-fed mice. The differentially expressed miRNAs putatively targeting INSR 3’UTR and IRS-1 3’UTR were screened computationally using publicly available algorithms (TargetScan: www.targetscan.org, Pictar: pictar.mdc-berlin.de, and miRWalk: www.umm.uni-heidelberg.de).
Acknowledgments
This research was supported by National Research Foundation of Korea (NRF) grants funded by Ministry of Education (2013R1A1A2057932) and Ministry of Science, ICT and Future Planning, South Korea (2016M2B2A4912473).
Footnotes
Transparency data associated with this article can be found in the online version at doi:10.1016/j.dib.2016.11.081.
Supplementary data associated with this article can be found in the online version at doi:10.1016/j.dib.2016.11.081.
Transparency document. Supplementary material
.
Appendix A. Supplementary material
.
.
References
- 1.Yang W.M., Jeong H.J., Park S.W., Lee W. Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes. Mol. Nutr. Food Res. 2015;59:2303–2314. doi: 10.1002/mnfr.201500107. [DOI] [PubMed] [Google Scholar]
- 2.Perry R.J., Samuel V.T., Petersen K.F., Shulman G.I. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510:84–91. doi: 10.1038/nature13478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–846. doi: 10.1038/nature05482. [DOI] [PubMed] [Google Scholar]
- 4.Park S.Y., Jeong H.J., Yang W.M., Lee W. Implications of microRNAs in the pathogenesis of diabetes. Arch. Pharm. Res. 2013;36:154–166. doi: 10.1007/s12272-013-0017-6. [DOI] [PubMed] [Google Scholar]
- 5.Hennessy E., O׳Driscoll L. Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert Rev. Mol. Med. 2008;10:e24. doi: 10.1017/S1462399408000781. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.